Advertisement
Researchers identified several socioeconomic and logistic barriers that limit diversity in clinical trials.
Recent advances have identified less controversial and more scalable stem cell sources than fetal tissue.
Black patients had lower rates of utilization and longer wait times for immunotherapy.
"... Though many newer therapies specifically target cancer cells, they can still interfere with heart function."
This research promotes progress in understanding how tumor genetics differs across individuals of different ancestry.
Addressing housing stability alone may not be enough to improve diabetes outcomes.
Expert Interviews
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.